Department of Pediatrics

Clinical Interests

Dr. Stokes is a Professor of Pediatrics at Washington University School of Medicine. Dr. Stokes did his early training at the University of Kansas Medical Center with his subsequent fellowships in Pediatric Pulmonary Medicine and Allergy/Immunology at the University of Wisconsin in Madison. He is board certified in Pediatrics, Pediatric Pulmonary Medicine, and Allergy and Clinical Immunology. After completing his training he was in private practice in Omaha, Nebraska for 3 years. Dr. Stokes then joined Creighton University School of Medicine where he was faculty for 14 years. Dr. Stokes primary clinic responsibility in Omaha was to care for the Military members and their families from the Offutt Air Force base. He was the Allergy/Immunology Fellowship Program Director for 12 years. He joined the faculty at Washington University in St. Louis the summer of 2016. His clinical and research interests include childhood asthma and the development of allergic diseases. Dr. Stokes looks forward to treating the children of the St. Louis area and their families.

Education

• BS, (cum laude) Pre-Med/Life Sciences, Kansas State University, 1987
• MD, University of Kansas Medical Center, 1991

Training

• Resident, Pediatrics, University of Kansas Medical Center, 1991 - 1994
• Fellow, Pediatric Pulmonology, University of Wisconsin Hospitals & Clinics, 1994 - 1997
• Fellow, Allergy & Immunology, University of Wisconsin Hospitals & Clinics, 1997 - 1998

Licensure and Board Certification

• 1992National Board of Medical Examiners
• 1994American Board of Pediatrics. Recertified 2000, 2008
• 1998American Board of Pediatric Pulmonology-Subspecialty. Recertified 2005, 2015
• 1998 - 2016Medical License, State of Nebraska
• 1999American Board of Allergy and Immunology. Recertified 2009, 2019
• 2005 - 2016Medical License, State of Iowa
• 2016 - PresMedical License, State of Missouri
• 2018 - PresMedical License, State of Illinois

Honors and Awards

• Hospitality Award-Ehrling Bergquist Hospital, 2003
• American College of Allergy, Asthma and Immunology: Clinical Fellowship Stipend Award, 2006 - 2008
• Best Doctors® in America, 2011 - Pres

Recent Publications view all (37)

Publication Co-Authors

Andrea Coverstone, M.D.

Katherine Rivera-Spoljaric, M.D., MSCI

Washington University has a long tradition of collaboration amongst colleagues.The faculty above have co-authored publications with Jeffrey Stokes, M.D.

1. Jackson DJ, Bacharier LB, Gergen PJ, Gagalis L, Calatroni A, Wellford S, Gill MA, Stokes J, Liu AH, Gruchalla RS, Cohen RT, Makhija M, Khurana Hershey GK, O'Connor GT, Pongracic JA, Sherenian MG, Rivera-Spoljaric K, Zoratti EM, Teach SJ, Kattan M, Dutmer CM, Kim H, Lamm C, Sheehan WJ, Segnitz RM, Dill-McFarland KA, Visness CM, Becker PM, Gern JE, Sorkness CA, Busse WW, Altman MC, US National Institute of Allergy and Infectious Disease's Inner City Asthma Consortium.. Mepolizumab for urban children with exacerbation-prone eosinophilic asthma in the USA (MUPPITS-2): a randomised, double-blind, placebo-controlled, parallel-group trial. Lancet. 2022;400(10351):502-511. PMID:35964610 
2. Phipatanakul W, Mauger DT, Guilbert TW, Bacharier LB, Durrani S, Jackson DJ, Martinez FD, Fitzpatrick AM, Cunningham A, Kunselman S, Wheatley LM, Bauer C, Davis CM, Geng B, Kloepfer KM, Lapin C, Liu AH, Pongracic JA, Teach SJ, Chmiel J, Gaffin JM, Greenhawt M, Gupta MR, Lai PS, Lemanske RF, Morgan WJ, Sheehan WJ, Stokes J, Thorne PS, Oettgen HC, Israel E, PARK Study Team.. Preventing asthma in high risk kids (PARK) with omalizumab: Design, rationale, methods, lessons learned and adaptation. Contemp Clin Trials. 2021;100:106228. PMCID:PMC7887056  PMID:33242697 
3. Stokes JR, Bacharier LB. Prevention and treatment of recurrent viral-induced wheezing in the preschool child. Ann Allergy Asthma Immunol. 2020;125(2):156-162. PMID:32454096 
4. Nelson RK, Bush A, Stokes J, Nair P, Akuthota P. Eosinophilic Asthma. J Allergy Clin Immunol Pract. 2020;8(2):465-473. PMID:31786254 
5. Stokes J. Anti-IgE Treatment for Disorders Other Than Asthma. Front Med (Lausanne). 2017;4:152. PMCID:PMC5613080  PMID:28983485 
6. Stokes JR, Casale TB. Characterization of asthma endotypes: implications for therapy. Ann Allergy Asthma Immunol. 2016;117(2):121-5. PMID:27499539 
7. Stokes JR, Casale TB. The use of anti-IgE therapy beyond allergic asthma. J Allergy Clin Immunol Pract. 2015;3(2):162-6. PMID:25609342 
8. Stokes JR. Promising future therapies for asthma. Int Immunopharmacol. 2014;23(1):373-7. PMID:24957689 
9. Casale TB, Stokes JR. Immunotherapy: what lies beyond. J Allergy Clin Immunol. 2014;133(3):612-9: quiz 620. PMID:24581428 
10. Stokes JR, Romero FA Jr, Allan RJ, Phillips PG, Hackman F, Misfeldt J, Casale TB. The effects of an H3 receptor antagonist (PF-03654746) with fexofenadine on reducing allergic rhinitis symptoms. J Allergy Clin Immunol. 2012;129(2):409-12, 412.e1-2. PMID:22196768 
11. Stokes JR, Casale TB. Allergic rhinitis and asthma: celebrating 100 years of immunotherapy. Curr Opin Immunol. 2011;23(6):808-13. PMID:21862303 
12. Nguyen TH, Stokes JR, Casale TB. Future forms of immunotherapy and immunomodulators in allergic disease. Immunol Allergy Clin North Am. 2011;31(2):343-65, x-xi. PMID:21530824 
13. Casale TB, Stokes JR. Future forms of immunotherapy. J Allergy Clin Immunol. 2011;127(1):8-15; quiz 16-7. PMID:21094518 
14. Dimov VV, Stokes JR, Casale TB. Immunomodulators in asthma therapy. Curr Allergy Asthma Rep. 2009;9(6):475-83. PMID:19814921 
15. Mehta V, Stokes JR, Berro A, Romero FA, Casale TB. Time-dependent effects of inhaled corticosteroids on lung function, bronchial hyperresponsiveness, and airway inflammation in asthma. Ann Allergy Asthma Immunol. 2009;103(1):31-7. PMID:19663124 
16. Bellamkonda P, Warrier P, Stokes JR, Chiang DT, Clark JP, Romero FA, Casale TB. Limitations of objective measures of asthma. Ann Allergy Asthma Immunol. 2009;102(6):530-1. PMID:19558014 
17. Warrier PJ, Bellamkonda P, Stokes JR, Casale TB. Utility and limitations of objective measures of asthma. Ann Allergy Asthma Immunol. 2009;102(6):518-22. PMID:19558012 
18. Casale TB, Stokes J. Anti-IgE therapy: clinical utility beyond asthma. J Allergy Clin Immunol. 2009;123(4):770-1.e1. PMID:19348915 
19. Hopp RJ, Stokes JR. The natural history of methacholine responsivenesss in the CAMP study: who becomes unresponsive? Am J Respir Crit Care Med. 2009;179(7):622; author reply 622-3. PMID:19318544 
20. Waggoner D, Stokes J, Casale TB. Asthma and obesity. Ann Allergy Asthma Immunol. 2008;101(6):641-3. PMID:19119710 
21. Waggoner D, Stokes J, Romero F, Casale TB. Dyspnea and obesity in African American women. Ann Allergy Asthma Immunol. 2008;101(6):644-5. PMID:19119711 
22. Segal M, Stokes JR, Casale TB. Anti-immunoglobulin e therapy. World Allergy Organ J. 2008;1(10):174-83. PMCID:PMC3651047  PMID:23282676 
23. Casale TB, Stokes JR. Immunomodulators for allergic respiratory disorders. J Allergy Clin Immunol. 2008;121(2):288-96; quiz 297-8. PMID:18269921 
24. Stokes JR. Allergy immunotherapy: indications, efficacy, and safety. J Respir Dis. 2008;29:136-141. 
25. Stokes J. Intranasal corticosteroids for the treatment of perennial allergic rhinitis. Southern Med J. 2007;100:667-668. 
26. Stokes JR, Casale TB. Allergy immunotherapy for primary care physicians. Am J Med. 2006;119(10):820-3. PMID:17000208 
27. Stokes J, Fenstad E, Casale TB. Managing impairment in patients with allergic rhinitis. Allergy Asthma Proc. 2006;27(1):12-6. PMID:16598987 
28. Stokes J, Fenstad E, Casale TB. Managing impairment in patients with allergic rhinitis. Allergy Asthma Proc. 2006;27:12-16. 
29. Lai L, Casale TB, Stokes J. Pediatric allergic rhinitis: treatment. Immunol Allergy Clin North Am. 2005;25(2):283-99, vi. PMID:15878456 
30. Stokes J, Kessler R, Philip G, Casale TB. Ragweed skin test responsiveness correlates with specific immunoglobulin E levels. Allergy Asthma Proc. 2005;26(2):103-7. PMID:15971467 
31. Stokes JR, Casale TB. Management of the patient with allergic asthma. Resident and Staff Physician. 2005;51:23-40. 
32. Stokes J, Casale TB. Rationale for new treatments aimed at IgE immunomodulation. Ann Allergy Asthma Immunol. 2004;93(3):212-7; quiz 217-9, 271. PMID:15478378 
33. Stokes JR, Hartel R, Ford LB, Casale TB. Cannabis (hemp) positive skin tests and respiratory symptoms. Ann Allergy Asthma Immunol. 2000;85(3):238-40. PMID:11030280 
34. Stokes JR, Sorkness RL, Kaplan MR, Castleman WL, Tomai MA, Miller RL, Lemanske RF Jr. Attenuation of virus-induced airway dysfunction in rats treated with imiquimod. Eur Respir J. 1998;11(2):324-9. PMID:9551732 
35. Stokes JR, Busse WW. Antileukotriene therapy in asthma. Semin Respir Crit Care Med. 1998;19(6):647-656. 
36. Stokes JR, Heatley DG, Lusk RP, Huddleston CT, Green CG. The bridging bronchus. Successful diagnosis and repair. Arch Otolaryngol Head Neck Surg. 1997;123(12):1344-7. PMID:9413366 
37. Stokes J, Kessler R, Philip G, Casale TB. Ragweed skin test responsiveness correlates with specific immunoglobulin E levels. Allergy and Asthma Proc. 26(2):103-107.